NanoBubble-Mediated Oxygenation : Elucidating the Underlying Molecular Mechanisms in Hypoxia and Mitochondrial-Related Pathologies
Worldwide, hypoxia-related conditions, including cancer, COVID-19, and neuro-degenerative diseases, often lead to multi-organ failure and significant mortality. Oxygen, crucial for cellular function, becomes scarce as levels drop below 10 mmHg (<2% O2), triggering mitochondrial dysregulation and activating hypoxia-induced factors (HiFs). Herein, oxygen nanobubbles (OnB), an emerging versatile oxygen delivery platform, offer a novel approach to address hypoxia-related pathologies. This review explores OnB oxygen delivery strategies and systems, including diffusion, ultrasound, photodynamic, and pH-responsive nanobubbles. It delves into the nanoscale mechanisms of OnB, elucidating their role in mitochondrial metabolism (TFAM, PGC1alpha), hypoxic responses (HiF-1alpha), and their interplay in chronic pathologies including cancer and neurodegenerative disorders, amongst others. By understanding these dynamics and underlying mechanisms, this article aims to contribute to our accruing knowledge of OnB and the developing potential in ameliorating hypoxia- and metabolic stress-related conditions and fostering innovative therapies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Nanomaterials (Basel, Switzerland) - 13(2023), 23 vom: 30. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Viafara Garcia, Sergio M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cancer |
---|
Anmerkungen: |
Date Revised 08.12.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/nano13233060 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365546607 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365546607 | ||
003 | DE-627 | ||
005 | 20231229123022.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/nano13233060 |2 doi | |
028 | 5 | 2 | |a pubmed24n1227.xml |
035 | |a (DE-627)NLM365546607 | ||
035 | |a (NLM)38063756 | ||
035 | |a (PII)3060 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Viafara Garcia, Sergio M |e verfasserin |4 aut | |
245 | 1 | 0 | |a NanoBubble-Mediated Oxygenation |b Elucidating the Underlying Molecular Mechanisms in Hypoxia and Mitochondrial-Related Pathologies |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 08.12.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Worldwide, hypoxia-related conditions, including cancer, COVID-19, and neuro-degenerative diseases, often lead to multi-organ failure and significant mortality. Oxygen, crucial for cellular function, becomes scarce as levels drop below 10 mmHg (<2% O2), triggering mitochondrial dysregulation and activating hypoxia-induced factors (HiFs). Herein, oxygen nanobubbles (OnB), an emerging versatile oxygen delivery platform, offer a novel approach to address hypoxia-related pathologies. This review explores OnB oxygen delivery strategies and systems, including diffusion, ultrasound, photodynamic, and pH-responsive nanobubbles. It delves into the nanoscale mechanisms of OnB, elucidating their role in mitochondrial metabolism (TFAM, PGC1alpha), hypoxic responses (HiF-1alpha), and their interplay in chronic pathologies including cancer and neurodegenerative disorders, amongst others. By understanding these dynamics and underlying mechanisms, this article aims to contribute to our accruing knowledge of OnB and the developing potential in ameliorating hypoxia- and metabolic stress-related conditions and fostering innovative therapies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a cancer | |
650 | 4 | |a drug delivery | |
650 | 4 | |a hypoxia | |
650 | 4 | |a innovation | |
650 | 4 | |a metabolism | |
650 | 4 | |a mitochondria | |
650 | 4 | |a molecular | |
650 | 4 | |a nanobubbles | |
650 | 4 | |a oxygen | |
650 | 4 | |a stress | |
700 | 1 | |a Khan, Muhammad Saad |e verfasserin |4 aut | |
700 | 1 | |a Haidar, Ziyad S |e verfasserin |4 aut | |
700 | 1 | |a Acevedo Cox, Juan Pablo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanomaterials (Basel, Switzerland) |d 2010 |g 13(2023), 23 vom: 30. Nov. |w (DE-627)NLM235444340 |x 2079-4991 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2023 |g number:23 |g day:30 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/nano13233060 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2023 |e 23 |b 30 |c 11 |